OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 08:26:26 2024-06-21 am EDT | ||
| 0.8 EUR | +3.90% |
|
| Current month | -27.36% | ||
| 1 month | -48.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 0.8 | +3.90% |
| 24-06-20 | 0.77 | +4.05% |
| 24-06-19 | 0.74 | -1.33% |
| 24-06-18 | 0.75 | +1.35% |
| 24-06-17 | 0.74 | -11.90% |
Real-time BOERSE MUENCHEN
Last update June 21, 2024 at 08:26 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GG75QB |
| ISIN | DE000GG75QB5 |
| Date issued | 2024-04-29 |
| Strike | 130.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.55 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.5 € |
|---|---|
| Lowest since issue | 0.72 € |
| Spread | 0.05 € |
| Spread % | 5.95% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.2
USD
Average target price
147
USD
Spread / Average Target
+6.37%
- Stock Market
- Certificates
- Certificat
